SUGGESTED CAUSE AND TREATMENT OF ASTHMA
6-9-10
INTRODUCTION
To date, asthma researchers do not know, or have not revealed, the root cause of asthma. The root cause is present every time asthma occurs--and, every time asthma occurs, the root cause is present.
The following asthma treatment and prevention Protocol was invented by an Iowalive net worker, using Iowalive's proprietary algorithms and data base, who generously provides the protocol to all, at no cost or obligation to anyone. The inventor, experienced at solving the most difficult problems, has no intention to file for a patent--but rather hopes for wide use of the Protocol. It is ready for trial testing, or trial use, and people are welcome to support such tests, or use, as desired--at their discretion.
The inventor receives no compensation or benefits from the producers of products suggested in the Protocol. Similarly, the inventor, and the nutrient supplement manufacturers, do not prescribe or make any specific health claims for the Protocol. Should anyone require medical advice for any health reason, they should consult their doctors and medical care providers.
It is the sole intent of the Protocol to synergize a thoroughly researched group of commonly used nutrients to halt conditions of asthma.
THE ROOT CAUSE OF ASTHMA
The inventor finds the root cause of asthma to be a long term, or acute, deficiency in Manganese and Molybdenum. Unfortunately, the inventor strongly suspects the causal deficiency levels might not always be detectable with available deficiency testing methods. This suspicion can be resolved by testing asthma patients for such deficiencies--using the best test methods available. If no deficiencies in patients are detected, supplementation with the two nutrients can commence to determine if symptoms are reduced.
If you enter asthma and manganese in a GOOGLE search, you will find about 174,000 references. Similarly, if you enter asthma and molybdenum in a GOOGLE search, you will find about 46, 000 results. Enter asthma, manganese and molybdenum in a GOOGLE search and you will find 295,000 results. The linkage of manganese and molybdenum with successfully treating asthma is not new to those outside the medical and pharmaceutical establishments.
The inventor has no knowledge of any side effects from the levels of the two common nutrients used in the Protocol. The supplements have been competitively marketed, likely for many years, without any known complaints from users.
However, the side effects of commonly accepted asthma drugs, prescribed by medical doctors etc., are described on website: http://asthma.about.com/od/asthmabasics/a/art_MED_SE.htm
The two supplements in the Protocol are available from most high quality food supplement stores. This alone has likely discouraged asthma researchers and pharmaceutical companies from pursuing a nutritionally based treatment for asthma.
The suggested low therapeutic dosages of the two minerals is possible because of the synergism of using both simultaneously.
Manganese Sources are: Liver and kidneys are the primary meat source of manganese. Wheat germ, legumes, nuts, and black tea are good plant sources. Sources of Molybdenum are: beans, dark green leafy vegetables , eggs, grains, legumes, liver, offal, peas, wheat, wheat germ, whole grains
SUGGESTED ASTHMA TREATMENT PROTOCOL
NORMALIZE BODY ENZYMES
TREATMENT PROTOCOL FOR ASTHMA—DEPENDING TO SOME EXTENT ON RESULTS OF PATIENT’S HEALTH RECORD REVIEW
FOLLOW-UP
AFTER 6 WEEKS, TEST FOR EVIDENCE OF IMPROVEMENT. IF SYMPTOMS ARE GONE, CONTINUATION OF PROTOCOL IS OPTIONAL.
IF ANY SYMPTOMS ARE DETECTED, CONTINUE PROTOCOL FOR NO MORE THAN 6 MORE WEEKS.
RESULTS EXPECTATIONS
80% OF EARLY OR MILD ASTHMA CASE PATIENTS WILL HAVE THEIR CONDITION REVERSED. IN ADDITION, ABOUT 80% OF THE MODERATE AND SERVER CASES WILL BE HALTED OR SLOWED. NO ADVERSE SIDE EFFECTS ARE EXPECTED. TOTAL SUPPLEMENT COST PER PATIENT IS LESS THAN $25, SINCE ALL ARE AVAILABLE OFF-THE-SHELF.
CLOSURE
THIS PROTOCOL IS SUBJECT TO REFINEMENT, BASED ON RESULTS OF EXTENSIVE USE.
USE OF THIS PROTOCOL SHOULD ALSO BE EFFECTIVE WHEN USED IN CONJUNCTION WITH OTHER ASTHMA TREATMENTS—WITHOUT CONFLICTS OR SIDE AFFECTS.